June 26, 2018 07:00
Bernard Lord | Photo : Réjean Meloche
Bernard Lord’s seat at the International Federation of Health Plans. Members of the insurance industry and the health from all the continents meet twice a year.
Specialists are invited to present advances in the field of health. “We learn several things,” said the ceo of Medavie. For example, governments of other countries have made appeals to private firms to assist in the resolution of public problems : problems of congestion emergency access of drugs. “
It reminds us that Canada is often compared to what is done in the United States. However, other models exist in countries that have values very similar to ours, ” said Mr. Lord.
“The experts came to tell us how many lives had been saved, how many complications had been avoided, thanks to the new model. “It urges the canadian industry to be open mind and to look at what is happening elsewhere in the world.
In addition to the demographic challenge, governments face financial situations in several difficult cases, ” said Mr. Lord. Canada does not escape, ” he said.
The debt, combined with the aging of the population, will put significant pressure on the public systems, ” said the former prime minister of New Brunswick. “Canadians expect to have services despite this context “, he adds.
Even if government is injecting funds in health, the private sector takes more and more place, observed Mr. Lord. To this effect, he cites the Canadian Institute for Health Information, which reports that 30 % of the health sector in Canada is private and 70 % is public. “New drugs and technologies to address health problems that it was almost impossible to adjust there are 10 or 15 years. “
The medication will continue to put pressure on the group plan, ” he said. “The health system has seen a reprieve in the last ten years with the arrival of new generics that have taken over from the drug by the end of the patent. With pharmacogenetics, another wave is coming. We will have to adapt, ” says Mr. Lord.
Medavie said to be successful in reducing certain costs, for example by disability, with best practices in the monitoring of employees. “We’re also exploring avenues to follow up the taking of drugs, to measure the effects and benefits, said Mr. Lord. I have seen in California people with a bracelet that warns them when the time comes to take their medication. It is important to keep an open mind. It is necessary to innovate not only at the level of the technology and pharmaceutical, but also of the thought. ”